.0% Audax Health Solutions, Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6% Chimerix, Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7% Epizyme, Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0% Glumetrics, Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM Intercept Pharmaceuticals, Inc. Therapeutic